Linked Life Data

8280653

Source:http://linkedlifedata.com/resource/pubmed/id/8280653

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1994-2-17
pubmed:abstractText
The availability of compounds effective against metastatic disease and at the same time excellently tolerated even in long-term administration has determined the choice of tamoxifen as primary treatment for palliation in metastatic breast cancer. Other drugs or other hormonal approaches were hardly tested against tamoxifen, especially as first-line treatment.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0923-7534
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
735-40
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Primary endocrine therapy for advanced breast cancer: to start with tamoxifen or with medroxyprogesterone acetate?
pubmed:affiliation
Swiss Group for Clinical Cancer Research (SAKK), Bern.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial